New hires and promotions in the biopharma industry, including: Aditx, Adverum, Axim, Gain, Gamida Cell, Homology, Krystal, Lixte, Notch, Proqr, Viralclear, Windtree.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Fx Solutions, Luminex, Neumodx, Phase Scientific.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Exero Medical, Fio, Fluidigm, Gnome Diagnostics, National Vision Holdings, Relay Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle, Masimo, Osteopore.

Med-tech firms raising money in public or private financings, including: 4D Medical, Nanovation, Propel(x).

New hires and promotions in the med-tech industry, including: Biodesix, Mannkind, Surgical Innovation Associates.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Generex, Immuron, Karyopharm, Molecular Partners, Neoimmunetech, Orchard, Orphazyme, Osmotica, Sanifit, Sorrento.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Albireo, Alexion, Can-Fite, Contrafect, Cytocom, Enlivex, Epsilogen, Geneuro, Imquest, Innovation, Inozyme, JW Therapeutics, Kedrion, Mateon, Metaclipse, PTC Therapeutics, Santhera, Sonnet, Vaxil.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Amplyx, Arcutis, Ascletis, Astrazeneca, Basilea, Bergenbio, Bioniz, Biontech, Bioxcel, Connect, Exelixis, Lantern, Pfizer, Synairgen, Vertex.

Biopharmas raising money in public or private financings, including: Annexon, Azurrx, Freeline, Frequency, Genix, Inozyme, Iteos, Magicmed, Nurix, Oncternal, Outlook, Processa.